A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
Armin Rashidi, Eric J. Huselton, Heather E. Stefanski, Todd E. DeFor, Ryan Shanley, Jaebok Choi, John F. DiPersio, Mark Juckett, Jeffrey S. Miller, Daniel J. Weisdorf, Mark A. Schroeder
Dive into the research topics of 'A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation'. Together they form a unique fingerprint.